BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 8542902)

  • 1. Fetal dose estimates and the ICRP abdominal dose limit for occupational exposure of pregnant staff to technetium-99m and iodine-131 patients.
    Mountford PJ; Steele HR
    Eur J Nucl Med; 1995 Oct; 22(10):1173-9. PubMed ID: 8542902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is it safe to work with iodine-131 if you are pregnant? A risk assessment for nuclear medicine staff involved with cleaning and decontamination.
    Barber RW; Parkin A; Goldstone KE
    Nucl Med Commun; 2003 May; 24(5):571-4. PubMed ID: 12717076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation dose to technicians per nuclear medicine procedure: comparison between technetium-99m, gallium-67, and iodine-131 radiotracers and fluorine-18 fluorodeoxyglucose.
    Chiesa C; De Sanctis V; Crippa F; Schiavini M; Fraigola CE; Bogni A; Pascali C; Decise D; Marchesini R; Bombardieri E
    Eur J Nucl Med; 1997 Nov; 24(11):1380-9. PubMed ID: 9371871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eye lens dosimetry in anesthesiology: a prospective study.
    Vaes B; Van Keer K; Struelens L; Schoonjans W; Nijs I; Vandevenne J; Van Poucke S
    J Clin Monit Comput; 2017 Apr; 31(2):303-308. PubMed ID: 26961500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation exposure of the families of outpatients treated with radioiodine (iodine-131) for hyperthyroidism.
    Barrington SF; O'Doherty MJ; Kettle AG; Thomson WH; Mountford PJ; Burrell DN; Farrell RJ; Batchelor S; Seed P; Harding LK
    Eur J Nucl Med; 1999 Jul; 26(7):686-92. PubMed ID: 10398815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurements of occupational exposure for a technologist performing 18F FDG PET scans.
    Biran T; Weininger J; Malchi S; Marciano R; Chisin R
    Health Phys; 2004 Nov; 87(5):539-44. PubMed ID: 15551792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation doses in the surroundings of patients undergoing nuclear medicine diagnostic studies.
    Gomez-Palacios M; Terrón JA; Domínguez P; Vera DR; Osuna RF
    Health Phys; 2005 Aug; 89(2 Suppl):S27-34. PubMed ID: 16010116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of personnel radiation dosimetry from myocardial perfusion scintigraphy: technetium-99m-sestamibi versus thallium-201.
    Culver CM; Dworkin HJ
    J Nucl Med; 1993 Jul; 34(7):1210-3. PubMed ID: 8315504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of exposure of workers to ionizing radiation from radioiodine and technetium in nuclear medicine departmental facilities.
    Krajewska G; Pachocki KA
    Med Pr; 2013; 64(5):625-30. PubMed ID: 24502125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safe radiation exposure of medical personnel by using simple methods of radioprotection while administering 131I-lipiodol therapy for hepatocellular carcinoma.
    Garin E; Laffont S; Rolland Y; Olivie D; Lecloirec J; Herry JY; Boucher E; Raoul JL; Bourguet P
    Nucl Med Commun; 2003 Jun; 24(6):671-8. PubMed ID: 12766603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation dose rates from adult patients undergoing nuclear medicine investigations.
    Mountford PJ; O'Doherty MJ; Forge NI; Jeffries A; Coakley AJ
    Nucl Med Commun; 1991 Sep; 12(9):767-77. PubMed ID: 1945188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation dose rates from patients undergoing PET: implications for technologists and waiting areas.
    Benatar NA; Cronin BF; O'Doherty MJ
    Eur J Nucl Med; 2000 May; 27(5):583-9. PubMed ID: 10853815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring and minimizing the radiation dose to nuclear medicine technologists.
    Lundberg TM; Gray PJ; Bartlett ML
    J Nucl Med Technol; 2002 Mar; 30(1):25-30. PubMed ID: 11948264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation dose rates from patients receiving iodine-131 therapy for carcinoma of the thyroid.
    Barrington SF; Kettle AG; O'Doherty MJ; Wells CP; Somer EJ; Coakley AJ
    Eur J Nucl Med; 1996 Feb; 23(2):123-30. PubMed ID: 8925845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of the helpless patient after radioiodine ablation therapy - are we being too strict?
    Williams CE; Woodward AF
    Nucl Med Commun; 2005 Oct; 26(10):925-8. PubMed ID: 16160653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioiodine therapy: care of the helpless patient and handling of the radioactive corpse.
    Greaves C; Tindale W
    J Radiol Prot; 2001 Dec; 21(4):381-92. PubMed ID: 11787894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [External exposure of hot cell operators in nuclear medicine].
    Sichirollo AE; Bombardieri E; Cortona G; Marchesini R
    Radiol Med; 1998 Dec; 96(6):612-7. PubMed ID: 10189927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are restrictions to behaviour of patients required following fluorine-18 fluorodeoxyglucose positron emission tomographic studies?
    Cronin B; Marsden PK; O'Doherty MJ
    Eur J Nucl Med; 1999 Feb; 26(2):121-8. PubMed ID: 9933345
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Brudecki K; Borkowska E; Gorzkiewicz K; Kostkiewicz M; Mróz T
    Radiat Environ Biophys; 2019 Aug; 58(3):469-475. PubMed ID: 30997611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of the Dose to the Family Members Taking Care of Thyroid Cancer Patients Undergoing I-131 Therapy in Nuclear Medicine Using TLD-100.
    Zehtabian M; Dehghan N; Danaei Ghazanfarkhani M; Haghighatafshar M; Sina S
    Radiat Prot Dosimetry; 2017 May; 174(4):541-544. PubMed ID: 27555655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.